Curriculum

Mind Over Memory: Early Identification and New Treatment Options for Alzheimer Disease

Doctor and patient are discussing at clinic

CME Information

1.75 AMA PRA Category 1 Credits™, 1.75 ABIM MOC or 1.72 AANP, 0.78 AANP Pharm

Release Date: 1/24/2024

Available for credit until 1/24/2025

Learning Objectives

  • Discuss the evaluation involved in diagnosing AD or MCI due to AD, including the expanding role of biomarkers to aid early and accurate diagnosis
  • Examine the roles of PCPs and dementia specialists in the diagnosis and management of AD
  • Explore the evidence supporting new and emerging anti-amyloid therapies
  • Consider which patients are most likely to benefit from these therapies
  • Answer frequently asked questions regarding advances in treatment for Alzheimer disease

Courses

Faculty

Jessica L. Zwerling, MD, MS
Daniel Press, MD, MMSc

Associate Professor of Neurology, Harvard Medical School, Boston, MA

Stephen P. Salloway, MD,MS

Supporters and Partners

Supported by

Eisai Inc.

Education Partner

Pri-Med Institute